AI assistant
Sending…
Sonoma Pharmaceuticals, Inc. — Director's Dealing 2017
Dec 1, 2017
35312_dirs_2017-12-01_5e8e15b1-dc0b-45aa-855d-bb5e104a5499.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sonoma Pharmaceuticals, Inc. (SNOA)
CIK: 0001367083
Period of Report: 2017-11-29
Reporting Person: MCLAUGHLIN JOHN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-11-29 | Common Stock, $0.0001 par value per share | A | 14317 | — | Acquired | 27778 | Direct |
Footnotes
F1: The stock was granted by the Issuer as a quarterly retainer as well as an annual grant pursuant to the Non-Employee Director Compensation Plan.
More from Sonoma Pharmaceuticals, Inc.
Capital/Financing Update
2026
Apr 30
Capital/Financing Update
2026
Apr 27
Capital/Financing Update
2026
Apr 17
Regulatory Filings
2026
Apr 9
Interim / Quarterly Report
2026
Feb 10
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 28
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 2
Director's Dealing
2026
Jan 2